Press Coverage

ISMP Updates: Remdesivir, Propofol, and Vincristine

Article quotes ISMP experts and summarizes ISMP alerts on errors with investigational use of remdesivir for COVID-19 patients, potential for overdoses with recently approved 2% propofol product, and updated vincristine labeling and packaging.

For the full text, visit Pharmacy Today online.

More News

Since the 2021-2022 influenza (flu) vaccine became available in September, the Institute for Safe Medication Practices (ISMP) has received multiple reports of mix-ups. Some patients have consented to a flu vaccine but received one of the COVID-19 vaccines instead, while others have received the flue